Risk assessment of new psychoactive substances - EMCDDA - Europa
Risk assessment of new psychoactive substances - EMCDDA - Europa
Risk assessment of new psychoactive substances - EMCDDA - Europa
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Risk</strong> <strong>assessment</strong> <strong>of</strong> <strong>new</strong> <strong>psychoactive</strong> <strong>substances</strong>: operating guidelinesconsiderable commitment <strong>of</strong> my colleagues from the Scientific Committee whoenjoyed a fruitful collaboration with <strong>EMCDDA</strong> staff and experts from the DutchNational Institute for Public Health and the Environment (RIVM) and the DutchNational Institute <strong>of</strong> Mental Health and Addiction (Trimbos Institute). Furthermore,the contributions made by the European Commission, Europol and the EuropeanMedicines Agency (EMEA) were crucial for ensuring the truly multidisciplinaryapproach <strong>of</strong> the guidelines.Finally, any risk <strong>assessment</strong> at an early stage <strong>of</strong> knowledge and scientific evidencewill inevitably contain some degree <strong>of</strong> inconclusiveness. However, I am optimisticthat through their implementation, the risk <strong>assessment</strong> guidelines will be furtheroperationalised so as to allow the <strong>EMCDDA</strong>’s Scientific Committee to present to theCommission and the Council analytical and sound evidence-based risk <strong>assessment</strong>reports.Dr Michael FarrellChair <strong>of</strong> the <strong>EMCDDA</strong>’s Scientific Committee12
Change language